Diaceutics (LON:DXRX) Trading Up 5.4% – Still a Buy?

Diaceutics PLC (LON:DXRX) shares were up 5.4% during mid-day trading on Wednesday . The stock traded as high as GBX 158 and last traded at GBX 155. Approximately 102,618 shares changed hands during trading, a decline of 49% from the average session volume of 200,059 shares. The stock had previously closed at GBX 147.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group reaffirmed a “buy” rating and set a GBX 215 target price on shares of Diaceutics in a research note on Wednesday, July 29th. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of GBX 215.

Diaceutics Stock Up 3.2%

The firm has a market capitalization of £134.93 million, a PE ratio of 1,445.45 and a beta of 0.88. The business’s fifty day moving average price is GBX 142.35 and its 200 day moving average price is GBX 149.95. The company has a quick ratio of 9.92, a current ratio of 3.43 and a debt-to-equity ratio of 2.85.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.